Cargando…
Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer
Proinflammatory signaling pathways are commonly up-regulated in breast cancer. In estrogen receptor-negative (ER(−)) and triple-negative breast cancer (TNBC), nitric oxide synthase-2 (NOS2) and cyclooxygenase-2 (COX2) have been described as independent predictors of disease outcome. We further explo...
Autores principales: | Basudhar, Debashree, Glynn, Sharon A., Greer, Madison, Somasundaram, Veena, No, Jae Hong, Scheiblin, David A., Garrido, Pablo, Heinz, William F., Ryan, Aideen E., Weiss, Jonathan M., Cheng, Robert Y. S., Ridnour, Lisa A., Lockett, Stephen J., McVicar, Daniel W., Ambs, Stefan, Wink, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5724261/ https://www.ncbi.nlm.nih.gov/pubmed/29087320 http://dx.doi.org/10.1073/pnas.1709119114 |
Ejemplares similares
-
Inducible nitric oxide synthase-derived extracellular nitric oxide flux regulates proinflammatory responses at the single cell level
por: Somasundaram, Veena, et al.
Publicado: (2019) -
Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density
por: Somasundaram, Veena, et al.
Publicado: (2022) -
Interferon-gamma is quintessential for NOS2 and COX2 expression in ER(-) breast tumors that lead to poor outcome
por: Cheng, Robert Y. S., et al.
Publicado: (2023) -
Role of nitric oxide in pancreatic cancer cells exhibiting the invasive phenotype
por: Fujita, Mayumi, et al.
Publicado: (2019) -
Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment
por: McGinity, Christopher L., et al.
Publicado: (2021)